Abstract Purpose of Review Angiotensin-converting enzyme inhibitors and angiotensin
receptor blockers are commonly used anti-hypertensive medications in a number of clinical …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

Renin-angiotensin-aldosterone system (RAAS) inhibitors, including angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are commonly used in …

J Clin Hypertens (Greenwich). 2012; 14: 407–414.© 2012 Wiley Periodicals, Inc. Important
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …

ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …

Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …

Background: Hypertension is an important healthcare challenge, yet despite initiatives to
improve detection and advances in therapy, the majority of patients do not achieve …

The renin–angiotensin–aldosterone system plays a major role in the pathophysiology of
hypertension and closely related cardio-and cerebrovascular events. Although both …

Angiotensin converting enzyme (ACE) inhibitors are increasingly important in
antihypertensive therapy because of their efficacy, tolerability, and specific benefits in …

As of the latest count in the US, there are 10 angiotensinconverting enzyme (ACE) inhibitors
and 7 angiotensin receptor blockers (ARBs) in the therapeutic arsenal. Although in meta …